These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10532114)

  • 21. [Development and use of anti-epithelial antibodies in solid tumors].
    Müller P; Schlimok G
    Internist (Berl); 2001 Jun; 42(6):827-34. PubMed ID: 11449629
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
    Wang X; Luo W; Foon KA; Ferrone S
    Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?
    Oldham RK
    J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552
    [No Abstract]   [Full Text] [Related]  

  • 25. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer vaccine shows benefit in solid tumors.
    Cancer Discov; 2014 Jul; 4(7):OF4. PubMed ID: 25002633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
    Coiffier B
    Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
    [No Abstract]   [Full Text] [Related]  

  • 29. Overview of monoclonal antibodies in cancer therapy: present and promise.
    Stern M; Herrmann R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials referral resource. Clinical trials using monoclonal antibodies.
    Davis T; Streicher H; Blatner G; Cheson BD
    Oncology (Williston Park); 1998 Oct; 12(10):1479, 1482, 1487. PubMed ID: 9798201
    [No Abstract]   [Full Text] [Related]  

  • 31. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
    Tanczos BT; Baumgart DC
    Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies for imaging and therapy.
    Epenetos AA; Kosmas C
    Br J Cancer; 1989 Feb; 59(2):152-5. PubMed ID: 2649128
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1996; 16():168-88. PubMed ID: 8639382
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects].
    Granov AM; Molchanov OE
    Vopr Onkol; 2008; 54(4):401-9. PubMed ID: 18942393
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement function in mAb-mediated cancer immunotherapy.
    Gelderman KA; Tomlinson S; Ross GD; Gorter A
    Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
    [No Abstract]   [Full Text] [Related]  

  • 39. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology evaluation: SGN-15, Seattle Genetics Inc.
    Smith S
    Curr Opin Mol Ther; 2001 Jun; 3(3):295-302. PubMed ID: 11497354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.